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Abstract 
A series of palladium(II) halo complexes of the types 
[PdX2L2].nH2O {n = 0, X = Cl, L = L4and L6; X = Br, L = L3, 
L4, L5 and L6;  n = 2, X = Cl, L = L3and L7, X = Br, L = L1}; 
Pd2X4L2 {X = Cl, Br, L = L2 and  L8} and Pd2X4L3 [X = Cl, L 
= L1; X = Br, L = L7] were prepared where L is 6-R-5,6-
dihydrobenzoimidazo quinazoline (R-Diq; where R = 
phenyl: L1/furyl: L2/thiophenyl: L3/o- or p-
hydroxyphenyl: L4, L5/o- or p-chlorophenyl: L6, 
L7/dimethylaminophenyl: L8and characterized by 
elemental analyses, molar conductivity measurements, 
TGA, infrared, electronic, NMR and mass spectral 
techniques. Based on these studies, monomeric/dimeric 
structure with a square planar geometry around the metal 
ion was proposed for these complexes. Anti-microbial 
activity for some of the synthesized complexes were 
investigated. 
Keywords: dihydrobenzoimidazoquinazoline, palladium(II), 
thermal analysis, mass spectra, biological activity. 
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1. Introduction 
N-heterocycles like imidazoles, benzimidazoles and quinazolines 
have the ability to stabilize various oxidation states of transition 
metals. Complexes of divalent palladium find application in 
catalysis [1,2], in biochemical reactions [3], in environment related  
studies [4] , as anticancer drugs [5] and in antimicrobial studies [6]. 
 
 
R-Diq; R = phenyl: L1/furyl: L2/thiophenyl: L3/o- or p-
hydroxyphenyl: L4, L5/o- or p-chlorophenyl: L6, 
L7/dimethylaminophenyl: L8 
2. Experimental 
2.1Reagents 
All the reagents were of analar grade. The solvents used were 
purified according to standard procedure. Palladiumchloride was 
obtained from Arora Matthey, Kolkata, India. N-heterocycles were 
prepared according to the published procedures [7 - 10].  
2.2Measurements 
Microanalyses were obtained from 240B Perkin – Elmer elemental 
analyzer. IR (nujol mull) spectra were recorded on Shimadzu FTIR 
8400s and far-ir spectra were recorded on a Bruker IFS 66 v/S 
instrument. Electronic spectra were recorded in DMF on Shimadzu 
UV 3101PC. FAB mass spectra were recorded on a JEOL SX102 
Mass Spectrometer at room temperature using Argon/Xenon as the 
FAB gas and m-nitrobenzyl alcohol as the matrix. NMR spectra 
were recorded on a Bruker WH 270 MHz and Bruker AMX 400 
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MHz (both equipped with Aspect 2000 computers) NMR 
Spectrometers in the solvent DMSO-d6. Molar conductivity 
measurements were made on a Systronic conductivity meter 304 - 
cell type CD-10.  
2.3Preparationof 6-R-5,6-dihydrobenzoimidazo[1,2-c] quinazoline 
derivatives (L1to L8) 
Synthesis and single crystal X – ray structural studies of the ligands 
L1, L2, L5and L8 were reported earlier [7 - 10]. Similar procedure 
was adopted for synthesis of other 6-R-5,6-dihydrobenzoimidazo 
[1,2-c] quinazoline derivatives (L3, L4,L6, andL7). These were 
synthesized as follows. A mixture of 2-aminophenylbenzimidazole 
(0.05mol) in 200 ml alcohol and the corresponding aldehydes (0.05 
mol) (thiophenaldehyde/) – hydroxybenzaldehyde /o-orp-
chlorobenzaldehyde) were refluxed for 5 hours. The resulting 
solution was concentrated under reduced pressure to a small 
volume to obtain a yellow compound. It was filtered and 
recrystallised from alcohol to get cream/white crystalline 
compound (yield: 60 -70 %).  
2.4Synthesis of the complexes  
The N-heterocycles L1 to L8  (1 mmol)were reacted with palladium 
halide (1 mmol)  (chloro and bromo) in presence of the respective 
halo acid in acetone in 1:2 ratio at refluxing temperature to afford 
complexes of the types[PdX2L2].nH2O {n = 0, X = Cl, L = L4 and L6; 
X = Br, L = L3, L4, L5 and L6; ; n = 2, X = Cl, L = L3 and L7, X = Br, L = 
L1}; Pd2X4L2 {X = Cl, Br, L = L2 and  L8} and Pd2X4L3 [X = Cl, L = L1; 
X = Br, L = L7] as yellow solids. Yield (45 – 50%). The chloro 
complex of L5 could not be isolated. The complexes were insoluble 
in common organic solvents but soluble in DMF and DMSO in 
which they behaved as non-electrolytes.  
The physical properties and analytical data of the complexes are 
compiled in table 1. 
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Table 1: The physical properties and analytical data of Pd(II) 
complexes of L1– L8. 
 
Complex Colour D.Pt 
(oC) 
Λ# Analytical data (%)* 
       C              H                N 
PdCl2L11.5 Yellow 295 24 58.78 
(57.79) 
2.82 
(3.64) 
10.26 
(10.11) 
[PdBr2L12]∙2H2O Bright 
yellow 
270 25 53.45 
(53.56) 
2.68 
(3.82) 
9.39 
(9.36) 
PdCl2L2 Pale 
yellow 
248 28 46.12 
(46.53) 
2.73 
(2.82) 
9.07 
(9.04) 
PdBr2L2 Bright 
yellow 
286 16 50.53 
(51.42) 
2.72 
(3.12) 
10.25 
(9.95) 
[PdCl2L32]∙2H2O Yellow 287 21 52.79 
(52.72) 
3.61 
(3.44) 
10.61 
(10.60) 
PdBr2L32 Yellow 303 12 50.44 
(49.53) 
3.58 
(3.00) 
9.99 
(9.63) 
PdCl2L42 Yellow 252 17 59.71 
(59.75) 
3.78 
(3.76) 
10.68 
(10.45) 
PdBr2L42 Yellow 260 22 53.16 
(53.80) 
3.89 
(3.38) 
9.67 
(9.41) 
PdBr2L52 Dark 
yellow 
271 20 53.63 
(53.80) 
3.14 
(3.39) 
9.04 
(9.41) 
PdCl2L62 Yellow 310 16 56.91 
(57.13) 
3.99 
(3.36) 
10.42 
(9.99) 
PdBr2L62 Yellow 302 17 51.86 
(51.67) 
3.69 
(3.04) 
9.60 
(9.04) 
[PdCl2L72]∙2H2O Brownish 
yellow 
255 29 54.47 
(54.79) 
3.52 
(3.22) 
8.83 
(9.58) 
PdBr2L71.5 Dark 
yellow 
286 31 48.53 
(48.83) 
2.59 
(3.48) 
8.86 
(8.54) 
PdCl2L8 Dark 
yellow 
312 16 51.98 
(51.03) 
3.16 
(3.89) 
10.88 
(10.82) 
PdBr2L8 Dark 
yellow 
273 22 43.52 
(43.55) 
3.33 
(3.50) 
9.24 
(9.29) 
   #: Ω-1cm2mol-1; (in DMF) *: calculated values are in parentheses. 
3.1 Infrared spectral studies 
IR spectra of the complexes were recorded as nujol mull and the 
Far-IR spectra were recorded as polyethylene pellets. IR spectra of 
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the complexes (Table 2) were similar to those of the ligands L1 to L8 
except for minor shifts in the position of the bands implying 
coordination of the N-heterocycles to the palladium(II) ion [11, 12]. 
The spectra of the chloro complexes of L3 and L7 and the bromo 
complex of L1 exhibited peaks at 3406, 3475, 3475 cm-1 respectively 
which can be attributed to the presence of lattice water in the 
molecule. The υC=N of benzimidazole and υC=C of benzimidazole 
and quinazoline groups were observed in the region 1616 – 1618 
cm-1 for the complexes as compared to the 1612 – 1620 cm-1 
exhibited by the ligands. υN-H of quinazoline ring was observed in 
the range 3240–3321 cm-1. The complexes exhibited υN-H in-plane 
bending vibration in the region 1577–1596 cm-1 and υC-N  and δNH in 
the range 1330–1346 cm-1. υC=C and δCH appeared in the region 1504–
1527cm-1. The complexes exhibited in–plane CH deformation and 
ring breathing modes between 1225 and 1269 cm-1 and CH out–of– 
plane deformation of quinazoline ring vibrations were observed in 
the range 1141–1189 cm-1. The Far-IR spectra of the complexes 
revealed the presence of stretching vibrations of the terminal Pd-Cl 
bond in the range 329-333 cm-1. The stretching frequencies of 
terminal Pd- Br bond was observed as twin forked peaks in the 
region 245–282 cm-1. The bridging Pd–Cl stretching vibrations of 
the chloro complexes of L2 and L8were observed at 265 and 294 cm-1 
and for the bromo complexes at 370 and 366 cm-1.  
3.2Electronic spectral studies 
The electronic spectra of the quinazoline derivatives and their 
complexes were recorded in DMF. They displayed bands (Table 2) 
in the region 27,000 and 38,000 cm-1 assignable to the π – π* and n– 
π* transitions of the N-heterocycles. The metal-to-ligand charge 
transfer transitions were observed in the region 22,200 to 28,000 cm-
1. They also exhibited weak bands in the range 19,200 to 22,700 cm-1 
assignable to the 1B1g → 1A1g transitions which are characteristic of a 
palladium(II) square planar complex [13 – 16].  
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Table 2: Electronic spectral data of the complexes (cm-1)*. 
Complex 
Ligand transitions MLCT d-d 
     n → π*                π → π* dπ → pπ 1B1g→ A1g 
Pd2Cl4L13 
36603(13182) 
34060(14868) 
32960(15427) 27473(8196) 22665(306) 
[PdBr2L12]∙2H2O 34083(22004) 33025(22859) 27518(9983) 21777(261) 
PdCl2L2 
35236(22078) 
33135(21077) 
30854(12177) 22442(1152) 20350(241) 
PdBr2L22 33944(14446) 32895(14221) 27609(7585) 22371(322) 
[PdCl2L32]∙2H2O 33933(18024) 32960(18249) 27405(6482) 23256(245) 
PdBr2L32 33289(27949) 32830(27210) 27518(8369) 22599(354) 
PdCl2L42 34200(37054) 32895 (31699) 26853(6914) 21524(666) 
PdBr2L42 34153(16135) 33003(14305) 26939(7097) 22163(397) 
PdBr2L52 
37878(18077) 
33829(13941) 
32851(13868) 
 
26969(6732)  
25075(4228) 
22634(434) 
PdCl2L62 
35236(26163) 
34083(27672) 
32895(25879) 
27042(10189) 
22242(2002) 
 
21368(67) 
PdBr2L62 
35361(26210) 
33967(28499) 
32895(26567) 
26969(14305) 
22272(421) 
 
20956(139) 
[PdCl2L72]∙2H2O 34412(13280) 33047(13749) 27996 (8042) 21749(193) 
Pd2Br4L73 
37565(14939) 
35638(14303) 
34341(14959) 
33047(15416) 
27870(8561) 20408(186) 
PdCl2L8 
37908(12786) 32873(13013) 25393(2035) 
25075(2598) 
19268(121) 
PdBr2L8 
37936(13154) 
33025(15111) 
31566(14166) 26154(2685) 19223(153) 
* in DMF 
3.3 NMR spectral studies  
The proton and 13C NMR spectra of the complexes were recorded 
in DMSO-d6. The spectra of the complexes resembled the spectra of 
the free N-heterocycles except for some minor shifts implying 
coordination of ligand to the metal ion. Ligand–to-metal σ– 
donation and metal-to-ligand π–back donation give rise to positive 
and negative coordination induced shifts (c.i.s.) of the peaks in the 
NMR spectra of metal complexes [17 – 19].  
a) 1HNMR spectral studies  
The 1H NMR spectral patterns of the complexes of L1 to L8 were 
comparable to their respective ligands except for the resonance 
signals due to the substituted R groups (Tables 3 and 4). The 
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resonance peak due to the NH of the quinazoline ring was 
observed as a singlet in the range 14.28 – 7.22 ppm and this was 
found to disappear in the spectra of the deuterated samples 
confirming it to be the NH proton. The CH of the quinazoline 
moiety was observed as a singlet in the range 7.60 – 7.00 δ was 
shifted by -0.41 to 0.34 ppm on complexation. The benzimidazole 
ring protons H-2′, 3′ 4′ and 5′ were found to resonate as multiplets 
in the range 8.09 – 6.92 ppm with c.i.s. of -0.59 – 0.36 ppm. The 
resonance signals of quinazoline ring protons H – 7, 8, 9 and 10 
were well resolved and appeared in the region 8.70 – 6.66 δ and 
were shifted by -0.33 to 0.76 δ on complexation. The phenyl protons 
of the substituted R group in the Pd(II) complex of L1 appeared in 
the range 7.54 – 7.20 δ with the H-3′ proton being most deshielded. 
The complexes of L2 and L3 contain O and S in the substituted R 
group respectively and the H-4 proton attached to the carbon atom 
bonded to the O/S were more deshielded and shifted downfield as 
compared to the H-2″ and 3″. These signals were found in the 
region 7.68 - 6.38 ppm with c.i.s of 0.03 – 0.88 ppm. The Pd(II) 
complexes of L4 and L5 were found to resonate in the region 7.83 - 
6.75 δ  and were shifted by 0.12 to 0.71 ppm on complexation. The 
hydroxyl proton appeared as an intense singlet in the downfield 
region of 10.20 and 9.66 δ for L4 and L5respectively and it was seen 
between 10.20 – 10.30 δ on complexation. The Pd(II) complexes of 
L6 and L7 exhibited peaks in the range 7.66 – 6.62 δ with positive 
and negative shifts in the range -0.62 to 0.65 δ. The protons of the 
complexes of L8 were found to resonate in the region 7.35 – 6.68 
ppm and were shifted by ~ 0.20 δ. The methyl protons in dimethyl 
amino group appeared around 1.88ppm and underwent a shift of 
0.94 ppm on complexation. The 1H NMR spectral data of the 
ligands L1 to L8 and their complexes are complied in tables 3 and 4. 
b) 13C NMR spectral studies 
The 13C NMR spectral pattern was similar for the complexes of L1 – 
L8except for the substituted R groups, table 3 and 4the carbon atom 
C-2 was found to be most deshielded being bonded to two nitrogen 
atoms and appeared in the downfield region between 154.80 – 
140.15 ppm. It exhibited an enormous shift of -5.88 – 7.06 ppm on 
complexation. C-4 of the heterocycles which is bonded to one 
nitrogen gave a signal in the downfield region 144.96 – 133.91 δ 
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with c.i.s. of -10.76 to 2.39 ppm. C-6 ′ and 7 ′ of the benzimidazole 
moiety being bonded to one nitrogen each were shifted down field 
in the ranges 139.14 – 127.87 δ and 145.26 - 138.66 δ respectively. 
The C-7 ′ is more deshielded of the two as it is bonded to tertiary 
nitrogen and appeared around 12 ppm. The benzimidazole carbons 
C – 3, 7, 8, 9 and 10 gave resonance signals in the range 134.51 - 
110.00 δ and exhibited large shifts in the range -8.88 – 8.55 δ on 
complexation. The benzimidazole ring carbons C - 2′, 3′, 4′ and 5′ 
are seen in the region 132.44 – 108.51 δ with c.i.s. of -3.18 – 3.42 
ppm. The resonance signal of C- 6 was observed in the range 73.77 
– 56.02 δ with c.i.s.  of -11.09 to 6.94 ppm on complexation.  
3.4 Mass spectral studies 
Electrospray mass spectrum of the complex Pd2Cl4L13 was carried 
out by dissolving the sample in acetonitrile. The ESI capillary was 
set at 3.5 kV and the cone voltage was 40V. Mass spectrum of the 
complex has revealed a molecular ion peak at 1248 which may be 
attributed to the dimeric molecular mass of the complex. Elemental 
composition of ions and their m/z values coincide with peaks 
produced by ESI - MS of Pd2Cl4L13 and thereby support the dimeric 
nature of the complex [20]. The data are compiled in the table 7. 
Table 7: Elemental composition of the ions and their m/z values 
produced by ESI-MS of Pd2Cl4L13. 
Complex/complex ions m/z Complex/complex ions m/z 
Pd2Cl4L3 1248 PdClL2 737 
Pd2Cl3L3 1211 PdL2 702 
Pd2Cl3L2 913 PdL(L - CH) 687 
Pd2Cl2L2 878 PdL 404 
Pd2ClL2 – 2H 841 L 298 
3.5 Thermogravimetric analysis 
Thermogravimetric analysis was carried out for the complexes 
[PdBr2L12]∙2H2O, [PdCl2L32]∙2H2O and [PdCl2L72]∙2H2O with heating 
rate of 15 oC/min (Table 8).  The water molecules were lost below 
100oC which suggest the lattice nature of water. The chloride ions 
were lost in the range 230 – 285 ºC followed by N-heterocycles 
which decomposed beyond 345 ºC. 
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Table 8: TGA data of the complexes 
Complex 
TGA data 
Temp. at which species lost (ºC) / % Weight loss 
(calculated) 
H2O                            Cl/Br                             L 
[PdBr2L12]∙2H2O 
72 / 
4.4 (4.5) 
230 – 269 / 
13.2 (13.2) 
345 / 
50.1 (50.2) 
[PdCl2L32]∙2H2O 
48 / 
4.5 (4.4) 
260 – 285 / 
13.1(13.0) 
364 / 
49.9 (50.0) 
[PdCl2L72]∙2H2O 
74 / 
4.0 (4.1) 
248 - 269 / 
12.2 (12.2) 
492 / 
50.1(50.0) 
4. Stereochemistry  
The coordination of the heterocycles to the Pd(II) ions were 
confirmed by the physical and analytical data, molar conductivity 
measurements, IR and 1H and 13C NMR spectral results. The 
electronic spectral results imply the presence of a square planar 
geometry around the metal ion. The far IR spectra reveal the 
presence of terminal and bridging halogens in the complexes with 
L2 and L8. TGA studies show the presence of lattice water in the 
chloro complexes of L3 and L7 and bromo complex of L1. Mass 
spectral data reveal the dimeric nature of the complex Pd2Cl4L13. 
From the above mentioned studies it can be inferred that the 
heterocycles behave as monodentate ligands except for chloro 
complex of L1 and bromo complex of L2 wherein they act as a 
bridging bidentate ligands. A monomeric structure I for the 
PdX2L2.nH2O type of complexes and a binuclear structure II and III 
for the Pd2X4L2 and Pd2X4L3 type of complexes respectively were 
proposed. 
L
L X
X
Pd
 
I 
PdX2L2 
X = Cl, L = L3, , L6, L7 ,L9 
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X = Br, L = L1, L3 – L6 
 
II 
Pd2X4L3 
X = Cl, R = Ph; L1 
X = Br; R = p-chlorophenyl; L7 
 
Pd Pd
X
X
X
X L
L
 
III 
Pd2X4L2 
X = Cl, Br; L = L2, L8 
5. Biological activities 
The test solutions containing palladium(II) complexes exhibited 
good antimicrobial properties at 100 ppm concentration for both 
strains of bacteria and the fungi Yeast. Six of the quinazoline 
derivatives L1– L5and L8 and their chloro complexes of Pd(II) were 
tested for in vitro growth inhibitory activity against Bacillus subtilis, 
E.coli and Yeast by cup - plate method (Table 9). Septran and 
ampicillin were used as the standard antibiotics for Bacillus subtilis 
and E.coli respectively while grissoflumin was used as the standard 
antifungal agent. The toxicity of the quinazoline derivatives against 
the microbes was found to be effective at 50 ppm concentration 
against Bacillus subtilis and Yeast and 100 ppm against E.coli. The 
Pd(II) complexes were found to be effective against the microbes at 
HR
N
N
N
H
H
R
N
N
N
H
H R
N
N
N
Pd
X
X
Pd
X
X
H
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100 ppm concentration. It was observed that the Pd(II) complexes 
exhibited lower inhibitory activity as compared to those of the 
quinazoline derivatives. Though the metal complexes and 
quinazoline derivatives proved to be toxic against microorganisms, 
the standard drugs were found to be more toxic. The ligands L2 and 
L8 were found to be ineffective against the microbe E.coli while 
ligandsL5 and L8 were found to be ineffective against the microbe 
Bacillus subtilis. The palladium complex PdCl2(L8) was found to be 
ineffective against the microbe Bacillus subtilis. The ligands and 
their complexes were moderately effective against Yeast. 
Table 9: Antimicrobial activity of the quinazoline derivatives and 
their complexes.* 
Compound
‡ 
Yeast  E.coli 
Bacillus 
subtilis 
Pd complex† Yeast  E.coli 
Bacillus  
subtilis 
 (L1) 40 45 46 PdCl2(L1)1.5 50 50 10 
 (L2) 50 Nd 46 PdCl2(L2)2 50 57 31 
 (L3) 50 75 50 PdCl2(L3)2.H2O 55 57 18 
 (L4) 65 76 40 PdCl2(L4)2 45 67 18 
 (L5) 70 50 Nd PdCl2(L5)2 55 50 18 
 (L8) 70 Nd Nd PdCl2(L8) 55 26 Nd 
Standard 67 76 76 PdCl2 63 75 47 
*: (%inhibition); nd: not detected; ‡: concentration: 50 ppm for Bacillus subtili,Yeast and 100 ppm for 
E.coli;  †: concentration: 100 ppm. 
Conclusion 
In conclusion, synthesis of chloro and bromo complexes of 
palladium(II) with dihydrobenzoimidazo quinazoline derivatives 
L1 – L8 were carried out and characterised by various 
physicochemical techniques. Based on these studies 
monomeric/dimeric structures with a square planar geometry 
around the palladium(II) ion have been proposed. Some of the 
complexes were tested for antimicrobial activity and were found to 
be moderately active. 
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Table 3: 1H NMR spectra of Pd(II) complexes with L1 –L5 (in ppm). 
   
 
 
         
   
Compound
/ 
Complex 
Quinazoline Benzimidazole R-Group 
NH CH 7 8 9 10 2′ 3′ 4′ 5′ 2″ 3″ 4″ 5″ 6″ 
(L1) 7.62s 7.08s 7.95 d 7.27 m   6.82 t 6.86 d 7.65 d 7.25 m 7.18 
m 
7.10 d 7.29 m 7.33 m 7.15 m 7.33 m 7.29 m 
PdCl2(L1)1.5 14.08s 7.34m 8.12d 7.53m 6.87t 7.04m 7.62m 7.45t 7.28m 7.28m 7.34m 7.54m 7.20t 7.34m 7.34m 
c.i.s 6.46 0.26 0.17 0.26 0.05 0.18 -0.03 -0.02 0.10 0.18 0.05 0.21 0.05 0.01 0.05 
PdBr2(L1)2∙2H2O 8.12m 7.32m 8.12m 7.52m 6.92t 7.02d 7.64m 7.32m 7.32m 7.32m 7.32m 7.42m 7.25m 7.42m 7.32m 
c.i.s 0.50 0.24 0.17 0.25 0.10 0.16 -0.01 0.07 0.14 0.22 0.03 0.09 0.10 0.09 0.03 
(L2) 7.63s 7.54s 7.94d 7.29t 6.86t 6.94d 7.67d 7.24m 7.22m 7.20m – 6.34m 6.36m 7.46d – 
PdCl2(L2) 7.66s 7.60s 8.38m 7.49m 6.99t 7.04d 7.08d 7.50m 7.50m 7.44m – 6.50m 6.50m 7.49m – 
c.i.s 0.03 0.06 0.44 0.20 0.13 0.10 -0.59 0.26 0.28 0.24 – 0.14 0.20 0.03 – 
PdBr2(L2) 7.63m 7.59m 8.70m 7.59m 7.36t 7.10d 8.09d 7.48m 7.48m 7.48m – 6.38m 6.40m 7.68m – 
c.i.s 0.03 0.05 0.76 0.30 0.50 0.10 0.42 0.24 0.26 0.28 – 0.04 0.04 0.22 – 
(L3) 7.57 s 7.44 s 7.95 d 7.30 t 6.87 t 6.93 d 7.65 d 7.22m 7.23m 7.19m – 6.34 d 6.34m 7.47 d – 
PdCl2(L3)2∙2H2O 14.06s 7.60m 8.34d 7.63m 7.36m 7.36m 7.91d 7.52m 7.52m 7.36m – 7.22m 7.22m 7.60m – 
c.i.s 6.49 0.16 0.39 0.33 0.49 0.43 0.26 0.30 0.29 0.17 – 0.88 0.88 0.13 – 
PdBr2(L3)2 7.66m 7.47m 8.18m 7.58m 7.18m 7.10d 7.75t 7.39m 7.47m 7.18m – 6.93m 6.93m 7.66m – 
c.i.s 0.09 0.03 0.23 0.28 0.31 0.17 0.10 0.17 0.24 -0.01 – 0.59 0.59 0.19 – 
 (L4) 7.26 s 7.09 s 7.96 d 7.26 t 6.64 t 6.68 d 7.66 d 7.06 t 6.87 t 6.90 d 10.20 s OH) 7.12m 6.80 t 7.19m 7.17m 
PdCl2(L4)2 14.28s 7.23m 8.24d 7.64m 6.90m 6.90m 7.97d 7.37m 7.23m 7.37m 10.30s 7.52m 7.23m 7.66m 7.62m 
c.i.s 7.02 0.14 0.28 0.38 0.26 0.22 0.31 0.31 0.36 0.47 0.10 0.40 0.43 0.47 0.45 
PdBr2(L4)2 7.56s 7.28m 8.02m 7.52m 6.82t 6.92m 8.02m 7.24m 6.92m 7.28m 10.25s 7.83d 6.92m 7.43m 7.43m 
c.i.s 0.30 0.19 0.06 0.26 0.18 0.24 0.36 0.18 0.05 0.38 0.05 0.71 0.12 0.24 0.26 
 (L5) 7.46 s 6.89 s 7.96 d 7.25 t 6.83 t 6.89 d 7.64d 7.16 t 7.06 t 6.96 d 7.02d 6.75 d 9.66 d  OH) 6.74 d 7.20 d 
PdBr2(L5)2 7.22s 7.08m 7.96d 7.13t 6.61t 6.66d 7.64d 7.06m 6.79m 7.06m 7.26m 6.90m 10.20s 6.87m 7.26m 
c.i.s -0.24 0.14 0.00 -0.12 -0.22 -0.23 0.00 -0.10 -0.27 0.10 0.24 0.15 0.54 0.13 0.06 
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 Table 4: 1H NMR spectra of Pd(II) complexes with L6 – L8 (in ppm). 
 
 
         
   
Compoun
d/ 
Complex 
Quinazoline Benzimidazole R-Group 
NH CH 7 8 9 10 2′ 3′ 4′ 5′ 2″ 3″ 4″ 5″ 6″ 
 (L6) 7.56 s 7.41 s 8.02 d 7.38 t 6.85m 6.89m 7.69 d 7.19 t 7.08 t 6.90 m - 7.58 d 7.26 m 7.24 m 6.97 m 
PdCl2(L6)2 14.06s 7.20m 8.35d 7.53m 7.20m 7.20m 7.93d 7.38m 7.38m 7.53m - 7.62m 7.62m 7.62m 7.62m 
c.i.s 6.50 -0.21 0.33 0.15 0.35 0.31 0.24 0.19 0.30 0.04 - 0.36 0.38 0.05 0.65 
PdBr2(L6)2 11.18m 7.00m 7.99m 7.35m 6.88m 7.00m 7.99m 7.16m 7.16m 7.35m - 7.62m 7.62m 6.62m 7.62m 
c.i.s 3.62 -0.41 -0.03 -0.03 0.03 0.11 0.30 -0.03 0.08 0.45 - 0.04 0.36 -0.62 0.65 
 (L7) 7.69 s 7.16 s 8.20 d 7.27 m 6.86 t 6.91 d 7.71d 7.22 m 7.14 m 7.25 m 7.42 d 7.31 - 7.31 d 7.42 d 
PdCl2(L7)2∙
2H2O 
14.07s 7.21m 8.35d 7.54m 7.21m 7.21m 7.93d 7.38m 7.38m 7.54m 7.63m 7.63m - -7.63m 7.63m 
c.i.s 6.34 0.05 0.15 0.27 0.35 0.30 0.23 0.16 0.14 0.29 0.21 0.32 - 0.32 0.21 
PdBr2(L7)1.5 14.07s 7.41m 7.87m 7.87m 7.46m 7.07d 7.87m 7.46m 7.46m 7.46m 7.58m 7.66d - 7.73d 7.58m 
c.i.s 6.38 0.25 -0.33 0.60 0.60 0.16 0.16 0.24 0.32 0.21 0.16 0.35 - 0.42 0.16 
 (L8) 7.40 s 6.86 s 7.96 d 7.24 t 6.81m 6.87m 7.62 d 7.06 t 7.02t 7.12 d 7.15 d 6.63 d 2.82 s  
(CH3)2 
6.63 d 7.15d 
PdCl2(L8) 14.09s 7.20m 7.92m 7.65m 7.20m 7.00m 7.92m 7.30t 7.30t 7.46m 7.34m 6.83m 1.88m 6.83m 7.34m 
c.i.s 6.69 0.24 -0.04 0.41 0.39 0.13 0.30 0.24 0.28 0.34 0.19 0.20 -0.94 0.20 0.19 
PdBr2(L8) 14.08m 7.20m 7.93m 7.66m 7.20m 7.00m 7.93m 7.30m 7.30m 7.44m 7.35m 6.83m 1.89m 6.83m 7.35m 
c.i.s 6.68 0.34 -0.03 0.42 0.13 0.31 0.24 0.28 -0.02 0.20 0.20 0.20 -0.93 0.20 0.20 
 
N
N
H H
4
3
1
2
5
6
7 8
9
10
1
'2'
3
'
4
'
6
'
7
'
5
'
N
R  
"
1"
2" 3"
4"
56"
 
O
1"
2"
3" 4"
5"
 
S
1"
2"
3" 4"
5"
 
OH
1"
2" 3"
4"
56" "
 
OH
1"
2" 3"
4"
5"6"
 
  
Table 5: 13C NMR for the ligands L1 to L4 and their Pd(II) complexes (in ppm). 
   
 
 
         
   
Compound/ 
complex 
Quinazoline Benzimidazole R-Group 
2 3 4 7 8 9 10 CH 2′ 3′ 4′ 5′ 6′ 7′ 1″ 2″ 3″ 4″ 5″ 6″ 
(L1) 146.80 111.80 143.11 124.59 131.61 118.13 114.76 67.80 118.55 122.13 121.98 110.47 140.31 143.80 132.78 128.88 125.94 128.88 125.94 128.88 
PdCl2(L1)1.5 146.40 111.42 143.51 124.93 133.73 118.23 114.96 67.93 118.55 124.04 124.04 111.02 139.10 144.36 134.52 128.90 126.05 129.26 125.83 128.90 
c.i.s -0.40 -0.38 2.39 0.34 2.12 0.10 0.20 0.13 0.00 1.91 2.06 -0.45 -1.21 0.56 1.74 0.02 0.11 0.38 -0.11 0.02 
PdBr2(L1)2∙2H2O 146.50 111.84 144.12 125.41 133.72 118.57 115.64 68.12 118.82 124.03 124.03 111.43 139.14 144.28 134.36 128.91 126.23 129.58 125.41 128.91 
c.i.s 0.10 0.04 1.01 0.82 2.12 0.44 0.88 -0.32 0.27 1.90 2.05 0.96 -1.17 0.48 1.58 0.03 -0.29 0.70 -0.53 0.03 
(L2) 147.20 112.29 143.40 125.14 132.19 118.94 110.62 61.83 119.14 122.93 122.83 108.37 132.89 143.74 - 152.36 110.83 110.83 115.42 - 
PdCl2(L2) 149.65 114.15 140.12 129.07 132.66 119.36 110.83 61.52 119.79 126.35 125.81 109.61 136.08 144.44 - 149.65 112.97 112.37 115.72 - 
c.i.s 2.45 1.86 -3.28 3.93 0.47 0.42 0.21 -0.31 0.64 3.42 2.88 1.24 3..9 0.07 - 2.71 2.14 1.54 0.30  
PdBr2(L2) 146.23 109.22 144.35 127.78 130.83 117.90 111.22 61.15 118.69 123.98 123.98 108.51 133.52 143.88 - 150.90 110.39 110.39 115.60 - 
c.i.s -0.978 -3.07 0.95 2.64 -1.36 -1.04 0.60 -0.68 -0.45 1.05 1.15 0.14 0.63 0.14 - -1.46 -0.44 -0.44 -0.18 - 
(L3) 149.86 113.71 144.47 125.96 135.98 119.40 114.13 61.89 129.24 126.41 125.22 109.69 131.71 144.77 - 144.35 112.58 104.53 115.79 - 
PdCl2(L3)2∙2H2O 147.05 119.88 139.11 126.47 134.51 124.25 122.63 63.51 132.44 129.03 125.04 119.89 133.25 140.21 - 139.11 121.91 112.23 112.88  
c.i.s -2.81 6.11 -5.36 0.51 -1.47 5.85 8.55 1.62 3.20 2.62 -0.73 1.02 1.54 -4.56 - -5.24 9.33 7.70 -2.87 - 
PdBr2(L3)2 143.98 111.36 133.91 124.06 127.10 118.79 116.12 63.65 126.52 124.67 122.59 110.60 127.87 142.05 - 130.66 115.40 104.53 118.28 - 
c.i.s -5.88 -2.35 -10.76 -1.90 -8.88 -0.61 1.99 1.76 -0.72 1.74 -3.18 0.91 -3.84 -2.52 - -13.69 -6.51 0.00 2.58 - 
 (L4) 147.24 111.45 143.39 124.47 131.39 118.46 114.66 62.96 119.16 122.01 121.84 110.09 132.78 143.75 129.87 154.9 
(OH) 
125.98 117.72 115.74 126.39 
PdCl2(L4)2 147.15 112.96 140.33 124.29 132.49 119.32 114.31 56.02 119.99 122.93 122.00 112.37 134.66 139.21 129.22 147..81 124.06 116.70 116.22 126.02 
c.i.s -0.09 1.51 -3.06 -0.81 1.10 0.86 -0.35 6.94 0.38 0.92 0.16 2.28 1.88 -4.54 -0.15 -6.38 -1.92 -1.02 -0.48 -0.37 
PdBr2(L4)2 154.30 114.06 144.96 124.98 130.96 119.24 114.78 65.48 119.24 123.95 123.95 112.17 135.29 145.26 127.91 155.25 125.64 117.75 116.10 125.36 
c.i.s 7.06 2.61 1.57 0.51 -0.43 0.78 0.12 2.52 -0.37 1.94 2.11 2.08 -2.51 1.51 -1.36 0.86 -0.34 0.03 0.36 -1.03 
 
N
N
H H
4
3
1
2
5
6
7 8
9
10
1
'2'
3
'
4
'
6
'
7
'
5
'
N
R  
"
1"
2" 3"
4"
56"
 
O
1"
2"
3" 4"
5"
 
S
1"
2"
3" 4"
5"
 OH
1"
2" 3"
4"
56" "
 
  
Table6: 13C NMR for the ligands L5 toL8 and their Pd(II) complexes (in ppm) . 
   
 
 
         
   
Compoun
d/ 
complex 
Quinazoline Benzimidazole R-Group 
2 3 4 7 8 9 10 CH 2′ 3′ 4′ 5′ 6′ 7′ 1″ 2″ 3″ 4″ 5″ 6″ 
(L5) 147.11 111.84 143.56 124.62 131.52 118.02 114.70 68.15 118.55 121.99 121.83 110.70 132.90 143.89 130.52 127.78 115.35 159.1 
(OH) 
115.3
5 
127.
78 
PdBr2(L5)2 143.77 112.82 141.94 125.49 131.82 122.24 122.11 73.77 122.24 123.48 124.34 112.48 133.75 143.77 131.82 129.08 118.32 149.55 118.8
2 
129.
08 
c.i.s 2.66 -0.04 -1.62 0.87 0.30 -4.22 7.71 5.62 3.09 1.57 2.51 1.78 0.85 -0.13 1.30 1.30 2.97 -9.55 3.47 1.30 
 (L6) 147.14 111.30 142.57 124.66 131.72 118.24 114.86 65.65 118.82 122.40 122.24 109.91 132.61 143.09 136.65 131.31 130.87 128.02 127.8
3 
130.
65 
PdCl2(L6)2 146.00 112.35 138.69 122.62 129.05 121.90 119.83 56.01 121.90 123.11 123.11 112.35 132.66 140.16 134.40 129.05 126.32 124.50 124.5
0 
126.
32 
c.i.s -1.14 1.05 -3.88 -1.64 -2.67 3.66 4.97 -9.64 3.08 0.71 0.87 2.44 0.05 -3.83 -2.25 -2.26 -4.55 -3.52 -3.33 -3.83 
PdBr2(L6)2 148.80 110.00 136.20 121.9 131.80 119.00 115.20 64.00 119.00 121.60 121.60 108.80 134.20 139.90 135.20 131.00 126.20 122.40 122.4
0 
126.
20 
c.i.s 1.66 -1.3 -6.37 -2.39 0.08 0.76 0.34 -1.65 0.18 -0.80 -0.64 -1.11 1.59 -4.09 -1.45 -0.31 -4.67 -5.62 -5.42 -3.95 
 (L7) 143.94 111.97 139.40 124.75 132.82 118.40 114.94 67.12 118.79 122.32 122.19 110.43 133.59 142.86 131.73 128.83 127.83 146.85 127.9
3 
128.
83 
PdCl2(L7)2∙
2H2O 
140.15 112.36 138.66 124.52 132.67 121.89 119.81 56.03 121.89 123.13 122.61 112.36 134.40 138.66 134.40 129.05 126.35 146.83 126.3
5 
129.
05 
c.i.s -3.79 0.39 -0.74 -0.23 -0.15 3.49 4.87 -11.09 3.10 0.81 0.42 1.93 0.81 -4.22 2.67 0.22 -1.48 0.08 -1.48 0.22 
PdBr2(L7)1.5 144.00 112.00 137.62 127.54 134.23 118.73 115.35 67.31 118.73 125.58 125.22 112.00 134.88 144.00 130.30 129.06 128.11 146.00 128.1
1 
129.
06 
c.i.s 0.06 0.03 -1.78 2.79 1.41 0.33 0.41 0.19 0.06 3.26 3.03 1.57 1.29 1.12 -1.43 0.23 0.28 -0.85 0.28 0.23 
(L8) 147.15 110.58 143.61 127.25 131.39 117.88 114.66 68.23 118.46 121.86 121.71 111.88 132.90 143.48 124.57 127.07 111.68 150.75 111.8
8 
127.
07 
PdCl2(L8) 145.5 110.89 144.34 130.96 133.34 118.65 118.22 66.92 119.15 123.76 123.61 111.79 134.62 144.40 125.36 127.75 115.60 147.00 115.6
0 
126.
96 
c.i.s -1.66 0.30 0.73 3.71 1.95 0.77 3.56 -1.31 0.69 1.90 1.90 -0.09 1.70 11.92 0.79 0.68 3.92 -3.75 3.92 -0.11 
PdBr2(L8) 145.5 110.30 143.5 130.66 131.94 117.74 115.45 66.53 117.93 123.68 122.33 110.93 133.40 144.29 124.59 127.50 114.85 146.14 114.8
5 
126.
74 
c.i.s -1.66 -0.28 -0.11 3.41 0.55 -0.14 0.79 -1.70 -0.53 1.82 0.62 -0.95 0.48 11.81 0.02 0.43 3.17 -4.61 2.97 -0.33 
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